Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
ACE Reports.
Osteoarthritis
The efficacy and safety of a fixed-dose combination of apocynin and paeonol, APPA, in symptomatic knee OA: A double-blind, randomized, placebo-controlled, clinical trial.
Osteoarthritis Cartilage. 2024 01-Jul;():. 10.1016/j.joca.2024.02.948
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
The efficacy and safety of a fixed-dose combination of apocynin and paeonol, APPA, in symptomatic knee OA: A double-blind, randomized, placebo-controlled, clinical trial.
Osteoarthritis Cartilage. 2024 01-Jul;():. 10.1016/j.joca.2024.02.948
Osteoarthritis
Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials
Osteoarthritis Cartilage. 2015 Apr;23(4):532-43.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials
Osteoarthritis Cartilage. 2015 Apr;23(4):532-43.